Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
0.2130
-0.0006 (-0.28%)
At close: Jan 30, 2026, 4:00 PM EST
0.2102
-0.0028 (-1.31%)
After-hours: Jan 30, 2026, 7:05 PM EST

Adial Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
4.613.752.8346.064.4
Cash & Short-Term Investments
4.613.752.8346.064.4
Cash Growth
-11.49%32.66%-29.35%-33.99%37.74%-35.06%
Prepaid Expenses
0.410.310.370.350.390.5
Other Current Assets
---0.430.010.23
Total Current Assets
5.014.063.24.786.465.14
Property, Plant & Equipment
----0.3-
Long-Term Investments
0.640.981.53---
Goodwill
----0.25-
Other Intangible Assets
00000.460.01
Other Long-Term Assets
---0.95-0.35
Total Assets
5.665.044.745.737.475.49
Accounts Payable
0.560.30.130.280.290.65
Accrued Expenses
0.60.680.531.142.380.86
Current Portion of Leases
----0.05-
Other Current Liabilities
---0.380.01-
Total Current Liabilities
1.150.980.651.792.721.51
Long-Term Leases
----0.21-
Long-Term Deferred Tax Liabilities
----0.02-
Other Long-Term Liabilities
---0.671.01-
Total Liabilities
1.150.980.652.463.971.51
Common Stock
0.020.01000.020.01
Additional Paid-In Capital
92.4686.0672.8866.9554.4335.49
Retained Earnings
-87.98-82-68.8-63.67-50.94-31.52
Shareholders' Equity
4.514.074.083.283.513.99
Total Liabilities & Equity
5.665.044.745.737.475.49
Total Debt
----0.26-
Net Cash (Debt)
4.613.752.8345.814.4
Net Cash Growth
-11.49%32.66%-29.35%-31.07%31.90%-35.06%
Net Cash Per Share
0.400.771.984.007.818.83
Filing Date Shares Outstanding
23.996.574.051.140.950.69
Total Common Shares Outstanding
23.846.471.661.070.840.58
Working Capital
3.863.082.552.993.743.63
Book Value Per Share
0.190.632.453.074.196.92
Tangible Book Value
4.54.064.083.272.83.98
Tangible Book Value Per Share
0.190.632.453.073.346.91
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q